亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

WHO 2024 hepatitis B guidelines: an opportunity to transform care

肝细胞癌 肝硬化 医学 传输(电信) 慢性肝炎 乙型肝炎病毒 公共卫生 慢性肝病 乙型肝炎 环境卫生 肝病 肝癌 病毒学 儿科 病毒 内科学 病理 电信 计算机科学
作者
Philippa Easterbrook,Niklas Luhmann,Sahar Bajis,Myat Sandi Min,Morkor Newman,Olufunmilayo Lesi,Meg Doherty
出处
期刊:The Lancet Gastroenterology & Hepatology [Elsevier BV]
卷期号:9 (6): 493-495 被引量:36
标识
DOI:10.1016/s2468-1253(24)00089-x
摘要

Chronic hepatitis B virus (HBV) infection is a major public health problem and cause of chronic liver disease and led to an estimated 1·1 million deaths in 2022, mainly due to cirrhosis and hepatocellular carcinoma. 1 WHOGlobal hepatitis report 2024: action for access in low- and middle-income countries. World Health Organization, Geneva2024https://www.who.int/publications/i/item/9789240091672Date accessed: April 9, 2024 Google Scholar In 2022, WHO estimated that 254 million people were living with chronic hepatitis B, of whom 65% were in the African and Western Pacific regions. 1 WHOGlobal hepatitis report 2024: action for access in low- and middle-income countries. World Health Organization, Geneva2024https://www.who.int/publications/i/item/9789240091672Date accessed: April 9, 2024 Google Scholar Most of this global burden can be attributed to mother-to-child transmission at the time of or shortly after birth and horizontal household transmission. Considerable progress has been made towards eliminating perinatal transmission of HBV through universal infant HBV immunisation, including timely hepatitis B birth-dose vaccination administered within 24 h of birth. This regimen is 90–95% effective in preventing infection and in reducing new infections among children. However, hepatitis B birth-dose coverage is only 45% globally, with particularly low coverage (18%) in the WHO African region. 2 WHOImmunization coverage. https://www.who.int/news-room/fact-sheets/detail/immunization-coverageDate accessed: March 14, 2024 Google Scholar For people with chronic hepatitis B, nucleoside analogue treatment with tenofovir or entecavir is highly effective, reducing progression of liver disease and incidence of hepatocellular carcinoma and improving long-term survival. However, a major testing and treatment gap remains. In 2022, only 13% of those living with chronic hepatitis B had been diagnosed and 3% treated. 1 WHOGlobal hepatitis report 2024: action for access in low- and middle-income countries. World Health Organization, Geneva2024https://www.who.int/publications/i/item/9789240091672Date accessed: April 9, 2024 Google Scholar Scaling up testing and treatment to reach the 90% testing and 80% treatment coverage targets and achieve the elimination goals will require radical simplification of treatment criteria, diagnostic approaches, and care pathways to overcome barriers in access to hepatitis B testing and treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
chunI发布了新的文献求助10
4秒前
我是老大的应助被肉包子采纳,获得10
6秒前
7秒前
fuyuting完成签到 ,获得积分10
9秒前
桐夜完成签到 ,获得积分10
10秒前
12秒前
14秒前
16秒前
Foloydon发布了新的文献求助10
17秒前
19秒前
斯文败类的应助被Foloydon采纳,获得10
21秒前
哈哈发布了新的文献求助10
22秒前
23秒前
25秒前
Drunk发布了新的文献求助10
29秒前
干净的中心完成签到,获得积分10
34秒前
挖掘机完成签到,获得积分10
37秒前
39秒前
41秒前
yann完成签到,获得积分10
42秒前
陌宸希完成签到 ,获得积分10
44秒前
学术雷锋发布了新的文献求助10
46秒前
EllenLawliet发布了新的文献求助10
49秒前
风中柚子完成签到 ,获得积分10
50秒前
51秒前
Ww完成签到,获得积分10
53秒前
fangmu完成签到,获得积分10
55秒前
无限的寡妇完成签到,获得积分10
55秒前
57秒前
深情安青的应助被Gary采纳,获得10
58秒前
59秒前
59秒前
Foloydon完成签到,获得积分10
1分钟前
LX有理想发布了新的文献求助10
1分钟前
1分钟前
Foloydon发布了新的文献求助10
1分钟前
机灵的月光完成签到,获得积分10
1分钟前
科研民工完成签到,获得积分10
1分钟前
上官若男的应助被Peter采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158598
求助须知:如何正确求助?哪些是违规求助? 9554358
关于积分的说明 21719087
捐赠科研通 7748128
什么是DOI,文献DOI怎么找? 3427032
关于科研通互助平台的介绍 2551902
邀请新用户注册赠送积分活动 2471277